Classification: Where Every CDSCO Application Starts
Under the Medical Devices Rules, 2017, Central Drugs Standard Control Organization (CDSCO) classifies every medical device and IVD into one of four risk-based categories:
- Class A (low risk)
- Class B (low–moderate risk)
- Class C (moderate–high risk)
- Class D (high risk)
Correct classification is extremely important, as the registration process, timeline, and document requirements all depend on the device class — it determines which licensing form applies, whether a Clinical Evaluation Report is required, and how likely the device is to face a facility inspection.
Getting classification right at the outset is the single most important step in the entire registration process, as it shapes every requirement that follows.
India Pathway at a Glance
| Route | Application / Licence | Authority | Indicative timeline |
|---|---|---|---|
| Import (foreign manufacturer) | MD-14 → MD-15 | CDSCO (Central Licensing Authority) | Up to 9 months under the Rules |
| Manufacture Class A/B | MD-3 → MD-5 | State Licensing Authority (audit by notified body) | 3–6 months |
| Manufacture Class C/D | MD-7 → MD-9 | CDSCO | 6–9 months (inspection likely) |
| Test licence (samples for testing/evaluation) | MD-16 → MD-17 (import); MD-12 → MD-13 (manufacture) | CDSCO | 1–2 months |
| Clinical investigation | MD-22 → MD-23 | CDSCO | Up to 90 days |
Import License – Form MD-14 & MD-15
Foreign manufacturers seeking to import medical devices into India must obtain an import license through a two-stage process. Form MD-14 is the application submitted by the Indian Authorized Agent through the CDSCO SUGAM portal, requesting the import license, while Form MD-15 is the actual license CDSCO issues once the MD-14 application is approved — the legal document that allows the device to be imported and sold in India.
In practice, the Authorized Agent matters more than most manufacturers expect. The agent signs the application, receives CDSCO communication and holds a Power of Attorney with an undertaking from you, authenticated in India or apostilled in your country. Choose an agent you trust, because they will be the face of your product to the regulator.
Because government fees and documentation requirements are charged per site and per distinct device, and vary by class, we help ensure your application is scoped correctly from the outset to avoid rework.
Device Master File (DMF) & Plant Master File (PMF) Preparation
A well-organized Device Master File (DMF) and Plant Master File (PMF) form the technical backbone of any CDSCO import license application. CDSCO's MD-14 checklist lists the categories of Device Master File evidence, and applicants are also expected to provide the latest competent-authority inspection or audit report from the previous three years, where available.
Both files follow formats set out in the Fourth Schedule of the Rules. The PMF describes the manufacturing site and its quality system. The DMF describes the device itself, from the executive summary and design through to verification, validation, labelling and release.
A well-aligned dossier can meaningfully reduce preventable regulatory queries and approval delays.
Manufacturing License – Form MD-5 & Form MD-9
Domestic manufacturers of Class A and B devices apply on Form MD-3 and receive a licence on Form MD-5 from the State Licensing Authority, after an audit by a CDSCO-registered notified body. Manufacturers of Class C and D devices apply on Form MD-7 and receive a licence on Form MD-9 from CDSCO, usually after a site inspection. We guide you through the QMS (Fifth Schedule), Device Master File, Plant Master File and inspection readiness for both routes.
Whether you're establishing new manufacturing operations in India or expanding existing ones, we help you navigate the licensing requirements specific to domestic production. This route carries its own documentation and inspection requirements, distinct from import licensing.
Clinical Evaluation Report (CER)
For Class C and D devices, a Clinical Evaluation Report is typically mandatory, and these higher-risk classes also face stricter eligibility criteria and a greater likelihood of overseas manufacturing site inspection, with CDSCO able to request a Medical Device Advisory Committee (MDAC) review before granting a license.
Strong clinical evidence is particularly critical for higher-risk devices, where CDSCO applies greater scrutiny throughout the review process.
Post-Approval Changes & License Retention
An MD-15 import license generally remains valid indefinitely, provided a retention fee is paid periodically (typically every five years) to keep the license active. Beyond retention, any changes to the device, manufacturer, or manufacturing site after approval must be reported to CDSCO as post-approval changes, ensuring the registration remains accurate and current.
Two practical points. The five-year clock runs from the date the base MD-15 was first issued, not from later endorsements, and the retention fee is set per site and per device. Missing the date can lead to penalties and, eventually, suspension or cancellation of the licence, so we suggest starting preparation well ahead.
Ongoing retention and change management support helps ensure your import license stays valid without unexpected lapses.
Query & Deficiency Letter Management
The CDSCO review process typically involves one or more deficiency letters, requiring applicants to respond within a defined window (commonly 7–14 days) to keep the application active and progressing. Delayed or incomplete responses are a common cause of stalled applications.
Proactive, responsive query management is often the difference between a smooth approval and a prolonged review cycle — and it's a core part of how we support you throughout the process.